AAD: Subcutaneous amlitelimab aids atopic dermatitis outcomes through week 24

Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and effective, with potentially progressive efficacy over time, for patients with moderate-to-severe atopic dermatitis (AD), according to the results of three phase 3 studies presented at the annual meeting of the American Academy of Dermatology, held from March 27 to 31 in Denver.

Fighting health myths: Report examines future of AI and crowdsourced truth

A new report investigates the technological frontline of the war on health misinformation. The article, "As Social Media Scales Back Fact-Checking, Can Technologies Fill the Gap?" by Wendy Glauser examines the shift from professional oversight to democratized and AI-driven moderation at a time when deepfakes and generative AI are accelerating the spread of life-threatening medical myths. The findings are published in the Journal of Medical Internet Research.

Study outlines how to embed dementia training in medical degrees

Australia's population is projected to age over the next 40 years and the number of centenarians is expected to increase six-fold. The number of Australians aged 65 and over will more than double, and the number of citizens aged 65 and over will more than triple. Data from the Australian Institute of Health and Welfare revealed 1 in 12 people aged 65 and over have dementia, rising to 2 in 5 for those aged 90 and over. This has prompted calls for the widespread introduction of dementia education in the education and training of health professionals.

A regulatory framework for AI that balances innovation with patient safety

As generative AI rapidly expands into mental health care, Utah has emerged as a national leader in developing a pragmatic, forward-looking regulatory framework that balances innovation with patient safety. In an npj Digital Medicine commentary, researchers and policymakers detail the state's early regulatory review of mental health AI agents and the legislative approach it helped shape.

Why smoking may raise dementia risk: Lung exosomes could disrupt brain iron balance

The correlation between smoking and neurodegeneration is well-documented, with one study from 2011 finding that heavy smoking in midlife was associated with a greater than 100% increase in risk of dementia, Alzheimer's and vascular dementia more than two decades later. Dementia is a less-studied impact of smoking for a simple, terrible reason: It occurs later in life and smokers tend to die younger.